Summary
Ten of 11 patients abruptly switched to placebos after several months of high daily doses (300–600 mg, 8–20 times the usual therapeutic range) of chlordiazepoxide experienced new symptoms and signs soon after. Depression, aggravation of psychoses, agitation, insomnia, loss of appetite, and nausea appeared between two and eight days following abrupt withdrawal. Two patients had seizures at seven and eight days. A third patient, not in the withdrawal study, had a seizure twelve days after discontinuation of a 300 mg daily dose. Plasma levels of drug indicated a half-life of approximately forty-eight hours following discontinuation of chronic high doses. Minor electroencephalographic abnormalities (mainly slowing) were produced by chronic administration of these exceedingly high doses. If large doses of chlordiazepoxide are used, the drug should not be abruptly discontinued.
Similar content being viewed by others
References
English, D. C.: Librium, a new nonsedative neuroleptic drug: A clinical evaluation Curr. Ther. Res. 2 (3), 88–91 (1960).
Harris, T. H.: Methaminodiazepoxide. J. Amer. med. Ass. 172, 1162–1163 (1960).
Hollister, L. E., E. M. Caffey Jr. and C. J. Klett: Abnormal symptoms, signs and laboratory tests during treatment with phenothiazine derivatives. A controlled study. Clin. Pharm. and Ther. 1, 284 (1969a).
Hollister, L. E., and F. S. Glazener: Withdrawal reactions from meprobamate, alone and combined with promazine: A controlled study. Psychopharmacologia 1, 336–341 (1960b).
Kinross-Wright, J., I. M. Cohen and J. A. Knight: The management of neurotic and psychotic states with Ro 5-0690 (Librium). Dis. nerv. Syst. 21, Suppl. 3, 23–26 (1960).
Randall, L. D.: Pharmacology of methaminodiazepoxide. Dis. nerv. Syst. 21, Suppl. 3, 7–10 (1960).
Tobin, J. M., I. F. Bird and D. E. Boyle: Preliminary evaluation of Librium (Ro 5-0690) in the treatment of anxiety reactions. Dis. nerv. Syst. 21, Suppl 3, 11–19 (1960).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hollister, L.E., Motzenbecker, F.P. & Degan, R.O. Withdrawal reactions from chlordiazepoxide (“Librium”). Psychopharmacologia 2, 63–68 (1961). https://doi.org/10.1007/BF00429621
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00429621